Regeneron's billionaire chief executive Leonard Schleifer has said that the drug industry's pricing is "ridiculous." So when his own new drug, Dupixent for eczema, was approved, he took an unorthodox path to setting its $37,000-a-year list price.
- Reuters•5 days ago
A federal judge has dismissed two of the six counterclaims that pharmacy benefits manager Express Scripts Holding Co raised in health insurer's Anthem Inc's $15 billion lawsuit claiming it charged too much for drugs. In a decision made public on Friday, U.S. District Judge Edgardo Ramos in Manhattan dismissed Express Scripts' claim that Anthem breached an implied covenant of good faith and fair dealing, saying it duplicated a breach of contract claim. Anthem had sued Express Scripts last March, accusing it of excessive pricing and operational failures.
- Motley Fool•7 days ago
Short-term pain with Molina Healthcare, Gilead Sciences, and Express Scripts stocks could still turn into long-term gains.
4XS.F : Summary for EXPRESS SCRIPTS HLDG - Yahoo Finance
Express Scripts Holding Company (4XS.F)
Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
At close: 3:14PM CEST
|Bid||0.00 x 50000|
|Ask||0.00 x 50000|
|Day's Range||59.81 - 60.12|
|52 Week Range||58.46 - 73.62|
|PE Ratio (TTM)||11.12|
|Dividend & Yield||0.00 (0.00%)|
|1y Target Est||N/A|